Gabapentinoïds and Hip Fracture: A Pharmacovigilance Comparative Study Between Gabapentin and Pregabalin

Emeny RT Chang CH Skinner J , et al Association of receiving multiple, concurrent fracture-associated drugs with hip fracture risk. JAMA Network Open. 2019;2(11):e1915348. doi:10.1001/jamanetworkopen.2019.15348

Leung MTY Turner JP Marquina C , et al Gabapentinoïds and risk of hip fracture. JAMA Netw Open. 2024;7(11):e2444488. doi:10.1001/jamanetworkopen.2024.44488

Bate A Lindquist M Edwards IR. The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database. Fundam Clin Pharmacol. 2008;22(2):127-140. doi:10.1111/j.1472-8206.2007.00552.x

Montastruc JL Sommet A Bagheri H Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011;72(6):905-908. doi:10.1111/j.1365-2125.2011.04037.x

Fusaroli M Salvo F Begaud B , et al The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): explanation and elaboration. Drug Saf. 2024;47(6):585-599. doi:10.1007/s40264-024-01423-7

Edwards R Aronson J. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-1129. doi:10.1016/S0140-6736(00)02799-9

Pierfitte C Bégaud B Lagnaoui R Moore ND. Is reporting rate a good predictor of risks associated with drugs? Br J Clin Pharmacol. 1999;47(3):329-331. doi:10.1046/j.1365-2125.1999.00881.x

Metcalf CS Smith MD Wilcox KS. Pharmacotherapy of the epilepsies. In: Brunton LL Knollmann BJ , eds. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 14th ed. Mc Graw Hill; 2023:385-411.

Sommet A Bénévent J Rousseau V , et al What fluoroquinolones have the highest risk of aortic aneurysm? A case/non-case study in VigiBase®. J Gen Intern Med. 2019;34(4):502-503. doi:10.1007/s11606-018-4774-2

Montastruc JL. Rhabdomyolysis and statins: a pharmacovigilance comparative study between statins. Br J Clin Pharmacol. 2023;89(8):2636-2638. doi:10.1111/bcp.15757